Clin Exp Emerg Med.
2017 Sep;4(3):121-127. 10.15441/ceem.17.226.
Review of the potential use of blood neuro-biomarkers in the diagnosis of mild traumatic brain injury
- Affiliations
-
- 1Department of Emergency Medicine, Bradford Royal Infirmary, Bradford, UK. Alastair.Jones@bthft.nhs.uk
- 2Global Medical Affairs, Abbott Point of Care, Princeton, NJ, USA.
- KMID: 2401239
- DOI: http://doi.org/10.15441/ceem.17.226
Abstract
- Head injury is a common presenting complaint amongst emergency department patients. To date, there has been no widespread utilization of neuro-biomarkers to aid the diagnosis of traumatic brain injury. This review article explores which neuro-biomarkers could be used in the emergency department in aiding the clinical diagnosis of mild traumatic brain injury. Based on the available evidence, the most promising neuro-biomarkers appear to be Glial fibrillary acidic protein (GFAP) and Ubiquitin C-Terminal Hydrolase Isozyme L1 (UCH-L1) as these show significant rises in peripheral blood levels shortly after injury and these have been demonstrated to correlate with long-term clinical outcomes. Treatment strategies for minor traumatic brain injury in the emergency department setting are not well developed. The introduction of blood neuro-biomarkers could reduce unnecessary radiation exposure and provide an opportunity to improve the care of this patient group.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Current State and Prospects of Development of Blood-based Biomarkers for Mild Traumatic Brain Injury
- Diagnostic History of Traumatic Axonal Injury in Patients with Cerebral Concussion and Mild Traumatic Brain Injury
- Central Pain Due to Traumatic Axonal Injury of the Spinothalamic Tract in Patients with Mild Traumatic Brain Injury
- Clinical Diagnostic Criteria of Mild Traumatic Brain Injury
- Animal Models of Traumatic Brain Injury
